相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment
Wouter B. Nagengast et al.
CANCER RESEARCH (2011)
VEGF-SPECT with 111In-bevacizumab in stage III/IV melanoma patients
Wouter B. Nagengast et al.
EUROPEAN JOURNAL OF CANCER (2011)
Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis
Koji Kitamura et al.
JOURNAL OF HEPATOLOGY (2011)
High-resolution imaging of human atherosclerotic carotid plaques with micro18F-FDG PET scanning exploring plaque vulnerability
Marleen G. Masteling et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2011)
PET with the 89Zr-Labeled Transforming Growth Factor-β Antibody Fresolimumab in Tumor Models
Thijs H. Oude Munnink et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies
Anton G. T. Terwisscha van Scheltinga et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
VEGF Blockade Inhibits Lymphocyte Recruitment and Ameliorates Immune-Mediated Vascular Remodeling
Jiasheng Zhang et al.
CIRCULATION RESEARCH (2010)
89Zr-bevacizumab PET imaging in renal cell carcinoma patients: feasibility of tumor VEGF quantification
S. F. Oosting et al.
EJC SUPPLEMENTS (2010)
89Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft
Thijs H. Oude Munnink et al.
EUROPEAN JOURNAL OF CANCER (2010)
89Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922
Wouter B. Nagengast et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
111In-Bevacizumab Imaging of Renal Cell Cancer and Evaluation of Neoadjuvant Treatment with the Vascular Endothelial Growth Factor Receptor Inhibitor Sorafenib
Ingrid M. E. Desar et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Imaging Atherosclerotic Plaque Inflammation by Fluorodeoxyglucose With Positron Emission Tomography
James H. F. Rudd et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature
Matthias Eder et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
Atherosclerotic plaque development and instability: A dual role for VEGF
Pieter W. Holm et al.
ANNALS OF MEDICINE (2009)
64Cu-Labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity
Lihui Wei et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Detection of inflammation in patients with acute aortic syndrome: comparison of FDG-PET/CT imaging and serological markers of inflammation
H. Kuehl et al.
HEART (2008)
In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft
Wouter B. Nagengast et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Atherosclerotic plaque progression and vulnerability to rupture - Angiogenesis as a source of intraplaque hemorrhage
R Virmani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett et al.
NATURE MEDICINE (2004)
From vulnerable plaque to vulnerable patient - A call for new definitions and risk assessment strategies: Part I
M Naghavi et al.
CIRCULATION (2003)
Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET
I Verel et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2003)
分享论文
